Drugmakers Will Ask US Government to Pause Drug Price Negotiations, Bloomberg News Reports
Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli […]
Eli Lilly
US FDA Revokes Authorization for Four COVID Antibody Drugs
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from
US FDA Revokes Authorization for Four COVID Antibody Drugs Read More »
Lilly’s Weight-Loss Drug Zepbound Wins US FDA Approval for Sleep Apnea
On Friday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) weight-loss treatment, Zepbound, for obstructive sleep apnea,
Lilly’s Weight-Loss Drug Zepbound Wins US FDA Approval for Sleep Apnea Read More »
In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
In Weight Loss Battle, Novo and Lilly Face Growing Offensive from Licensed Copies Read More »
Lilly’s Mounjaro Gains Market Share Over Wegovy in UK’s Private Obesity Drug Market
LONDON – Britons paying privately for obesity drugs are increasingly choosing Eli Lilly’s (NYSE: LLY) Mounjaro over Novo Nordisk’s (NYSE:
Lilly’s Mounjaro Gains Market Share Over Wegovy in UK’s Private Obesity Drug Market Read More »
Trump, RFK Jr. Met with Pfizer, Lilly Executives: Report
President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) as
Trump, RFK Jr. Met with Pfizer, Lilly Executives: Report Read More »
Novo, Lilly Shares Rise as Biden Proposes Obesity Care Coverage
COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after
Novo, Lilly Shares Rise as Biden Proposes Obesity Care Coverage Read More »
Americans Seeking Weight-Loss Drugs Face Supply and Insurance Hurdles
Americans are still eagerly seeking prescriptions for Eli Lilly’s (NYSE: LLY) and Novo Nordisk’s (NYSE: NVO) weight-loss and diabetes drugs
Americans Seeking Weight-Loss Drugs Face Supply and Insurance Hurdles Read More »
US Medicaid Programs Say Cost a Key Factor for Weight-Loss Drug Coverage, Survey Finds
NEW YORK – Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk (NYSE: NVO) and
US Medicaid Programs Say Cost a Key Factor for Weight-Loss Drug Coverage, Survey Finds Read More »
